236 related articles for article (PubMed ID: 10439378)
1. Acute neutrophilic dermatosis induced by all-trans-retinoic acid treatment for acute promyelocytic leukemia.
Levi I; Raanani P; Shalmon B; Schiby-Brilliant R; Ben-Bassat I
Leuk Lymphoma; 1999 Jul; 34(3-4):401-4. PubMed ID: 10439378
[TBL] [Abstract][Full Text] [Related]
2. Sweet's syndrome associated with retinoic acid syndrome in a patient with promyelocytic leukemia.
Astudillo L; Loche F; Reynish W; Rigal-Huguet F; Lamant L; Pris J
Ann Hematol; 2002 Feb; 81(2):111-4. PubMed ID: 11907794
[TBL] [Abstract][Full Text] [Related]
3. Sweet's syndrome--like neutrophilic lobular panniculitis associated with all-trans-retinoic acid chemotherapy in a patient with acute promyelocytic leukemia.
Jagdeo J; Campbell R; Long T; Muglia J; Telang G; Robinson-Bostom L
J Am Acad Dermatol; 2007 Apr; 56(4):690-3. PubMed ID: 17367621
[TBL] [Abstract][Full Text] [Related]
4. Sweet's syndrome in a patient with acute promyelocytic leukemia during treatment with all-trans retinoic acid.
Shirono K; Kiyofuji C; Tsuda H
Int J Hematol; 1995 Oct; 62(3):183-7. PubMed ID: 8589363
[TBL] [Abstract][Full Text] [Related]
5. Sweet's syndrome during treatment with all-trans retinoic acid in a patient with acute promyelocytic leukemia.
Arun B; Berberian B; Azumi N; Frankel SR; Luksenburg H; Freter C
Leuk Lymphoma; 1998 Nov; 31(5-6):613-5. PubMed ID: 9922053
[TBL] [Abstract][Full Text] [Related]
6. Sweet's syndrome during the treatment of acute promyelocytic leukemia with all-trans retinoic acid.
Park CJ; Bae YD; Choi JY; Heo PS; Lee KS; Park YS; Lee JA
Korean J Intern Med; 2001 Sep; 16(3):218-21. PubMed ID: 11769583
[TBL] [Abstract][Full Text] [Related]
7. Sweet's syndrome associated with trans-retinoic acid treatment in acute promyelocytic leukaemia.
Cox NH; O'Brien HA
Clin Exp Dermatol; 1994 Jan; 19(1):51-2. PubMed ID: 8313637
[TBL] [Abstract][Full Text] [Related]
8. Sweet's syndrome followed by retinoic acid syndrome during the treatment of acute promyelocytic leukemia with all-trans retinoic acid.
Takada S; Matumoto K; Sakura T; Shiozaki H; Miyawaki S
Int J Hematol; 1999 Jul; 70(1):26-9. PubMed ID: 10446491
[TBL] [Abstract][Full Text] [Related]
9. Sweet's syndrome involoving the musculoskeletal system during treatment of promyelocytic leukemia with all-trans retinoic acid.
Christ E; Linka A; Jacky E; Speich R; Marincek B; Schaffner A
Leukemia; 1996 Apr; 10(4):731-4. PubMed ID: 8618455
[TBL] [Abstract][Full Text] [Related]
10. [Development of Sweet's syndrome during all-trans retinoic acid therapy for acute promyelocytic leukemia].
Ueno R; Takeuchi J; Shimizu T; Kumagai T; Sawada U; Horie T
Rinsho Ketsueki; 2000 Sep; 41(9):718-22. PubMed ID: 11070932
[TBL] [Abstract][Full Text] [Related]
11. [Development of Sweet syndrome in an acute promyelocyte leukemia patient during treatment with all-trans retinoic acid--case report and literature review].
Yan ZS; Li DP; Jiang EL; Zhou CL; Liu EB; Chen HS; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):462-5. PubMed ID: 18072629
[TBL] [Abstract][Full Text] [Related]
12. Acute neutrophilic dermatosis with myeloblastic infiltrate in a leukemia patient receiving all-trans-retinoic acid therapy.
Piette WW; Trapp JF; O'Donnell MJ; Argenyi Z; Talbot EA; Burns CP
J Am Acad Dermatol; 1994 Feb; 30(2 Pt 2):293-7. PubMed ID: 8294584
[TBL] [Abstract][Full Text] [Related]
13. Vasculitis associated with all trans retinoic acid (ATRA) in a case with acute promyelocytic leukemia.
Paydas S; Yavuz S; Disel U; Sahin B; Canbolat T; Tuncer I
Leuk Lymphoma; 2003 Mar; 44(3):547-8. PubMed ID: 12688331
[TBL] [Abstract][Full Text] [Related]
14. Sweet syndrome developing during treatment with all-trans retinoic acid in a child with acute myelogenous leukemia.
Al-Saad K; Khanani MF; Naqvi A; Krafchik B; Grant R; Pappo A
J Pediatr Hematol Oncol; 2004 Mar; 26(3):197-9. PubMed ID: 15125614
[TBL] [Abstract][Full Text] [Related]
15. All-trans-retinoic acid-induced myositis in a child with acute promyelocytic leukemia.
Citak FE; Ezer U; Akkaya E; Ozbulbul N; Bahce M; Kurekci AE
Haematologica; 2006 Aug; 91(8 Suppl):ECR35. PubMed ID: 16923519
[TBL] [Abstract][Full Text] [Related]
16. Hypercalcemia due to all trans retinoic acid in the treatment of acute promyelocytic leukemia potentiated by voriconazole.
Bennett MT; Sirrs S; Yeung JK; Smith CA
Leuk Lymphoma; 2005 Dec; 46(12):1829-31. PubMed ID: 16263588
[TBL] [Abstract][Full Text] [Related]
17. Scrotal Ulcers Arising during Treatment with All-trans Retinoic Acid for Acute Promyelocytic Leukemia.
Shimizu D; Nomura K; Matsuyama R; Matsumoto Y; Ueda K; Masuda K; Taki T; Nishida K; Horiike S; Kishimoto S; Yanagisawa A; Taniwaki M
Intern Med; 2005 May; 44(5):480-3. PubMed ID: 15942099
[TBL] [Abstract][Full Text] [Related]
18. ATRA-induced myositis in induction therapy of acute promyelocytic leukemia.
Martínez-Chamorro C; Martínez E; Gil-Fernández JJ; Alonso A; Escudero A; Fernández-Rañada JM
Haematologica; 2002 Feb; 87(2):ECR08. PubMed ID: 11836177
[No Abstract] [Full Text] [Related]
19. All-trans-retinoic acid-induced myositis: a description of two patients.
van Der Vliet HJ; Roberson AE; Hogan MC; Morales CE; Crader SC; Letendre L; Pruthi RK
Am J Hematol; 2000 Feb; 63(2):94-8. PubMed ID: 10629576
[TBL] [Abstract][Full Text] [Related]
20. Acute renal failure during ATRA treatment.
Yarali N; Tavil B; Kara A; Ozkasap S; Tunç B
Pediatr Hematol Oncol; 2008 Mar; 25(2):115-8. PubMed ID: 18363177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]